Profusa's Presentation at the H.C. Wainwright Conference
Berkeley, Calif. -- Profusa, Inc. (NASDAQ: PFSA), a trailblazer in digital health, is excited to announce its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference. This conference, a significant platform for investors, is scheduled to take place over a few days during September at a prestigious hotel in New York.
CEO Insight: Dr. Hwang's Overview
Ben Hwang, Ph.D., the Chief Executive Officer of Profusa, is set to present an insightful overview of the company. Attendees will gain a deeper understanding of Profusa's innovative technology that focuses on continuous monitoring of an individual's biochemistry. Dr. Hwang's presentation will be made available for interested registered investors starting from September 5.
Engagement Opportunities for Investors
The conference will also provide opportunities for one-on-one meetings with key members of the Profusa team. Interested parties are encouraged to register for the event to engage directly with Profusa's leadership, discussing the company’s future directions and growth potential.
About Profusa and Its Mission
Founded in Berkeley, Calif., Profusa is driven by a dedicated team of scientific visionaries and a robust management crew. The company is revolutionizing healthcare with its tissue-integrated sensors, which are engineered to provide continuous and actionable medical data. With the aim of empowering individuals to take charge of their health, Profusa develops affordable biosensors that deliver invaluable insights to both patients and clinicians.
The Future of Health Monitoring Technology
Profusa stands at the forefront of health technology advancements. Their unique products, which include long-lasting, injectable biosensors, represent a leap forward in personal health monitoring. The company's approach is to create a biochemical signature that offers a reliable source of health data—a tool that can potentially transform individual healthcare experiences.
Committed to an Innovative Future
With strong industry positioning, Profusa is committed to delivering meaningful innovations in digital health. By continuously enhancing their technology and data platforms, they ensure accessibility and reliability for users, making significant strides towards better health outcomes.
Frequently Asked Questions
What will Profusa's presentation cover?
Dr. Hwang's presentation will provide insights into Profusa’s latest advancements in digital health and their continuous monitoring technology.
When is the H.C. Wainwright Conference being held?
The H.C. Wainwright conference is scheduled for September 8-10, during which Profusa will present.
How can investors engage with Profusa?
Investors can register for the conference to request one-on-one meetings and learn more about Profusa's strategic vision.
What is Profusa's mission?
Profusa is dedicated to transforming health monitoring through its innovative biosensor technology aimed at providing actionable health data.
What does NASDAQ: PFSA represent?
NASDAQ: PFSA denotes the stock ticker for Profusa, Inc., which is publicly traded and focuses on digital health innovations.
